Related Experiment Video
Updated: Jun 26, 2025
08:21
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
6.9K
GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases, Current Status and Future Perspective.
Yan Fan1, Xiao-Yan Yan1, Wei Guan2
1Department of Pharmacy, Zhangjiagang Second People's Hospital, Zhangjiagang 215600, Jiangsu, China.
Current Drug Targets
|May 16, 2024
Summary
Human G protein-coupled receptor 56 (GPR56) dysfunction is linked to depression and cancer. Targeting GPR56 may improve treatments for these conditions.
Area of Science:
- Molecular biology
- Neuroscience
- Oncology
Background:
- G protein-coupled receptor 56 (GPR56), an adhesion GPCR, is found in the central nervous system and tumors.
- GPR56 dysfunction is associated with brain development, neuropsychiatric disorders, cardiovascular diseases, and cancer progression.
- GPR56 influences treatment susceptibility for antipsychotics and anticarcinogens.
Purpose of the Study:
- To review the molecular structure and signaling pathways of GPR56.
- To summarize GPR56's role in psychiatric disorders and cancer.
- To explore GPR56 as a therapeutic target.
Main Methods:
- Literature review of GPR56's molecular structure and signaling.
- Comprehensive summary of GPR56's function in disease pathogenesis.
- Elucidation of downstream signaling pathways.
Main Results:
- GPR56 deficiency is linked to depressive behaviors and reduced antipsychotic efficacy.
- Upregulated GPR56 promotes proliferation and metastasis in glioblastoma, colorectal, and ovarian cancers.
- Specific GPR56 signaling pathways involved in disease pathogenesis were identified.
Conclusions:
- GPR56 plays a critical role in psychiatric disorders and cancer.
- GPR56 represents a promising therapeutic target for improving treatment outcomes.
- Further research into GPR56 mechanisms can enhance therapeutic strategies.
More Related Videos
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
13.7K
09:12G Protein-selective GPCR Conformations Measured Using FRET Sensors in a Live Cell Suspension Fluorometer Assay
Published on: September 10, 2016
9.6K
Related Concept Videos
01:30Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
01:15G Protein-coupled Receptors
11.8K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.8K
01:12GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
01:21G-protein Coupled Receptors
118.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.4K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
01:22Activation and Inactivation of G Proteins
7.1K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.1K